This HTML5 document contains 65 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1046/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73016743
rdf:type
wikibase:Item
schema:description
im Januar 1997 veröffentlichter wissenschaftlicher Artikel articolo scientifico (pubblicato il 1997) wetenschappelijk artikel artículu científicu espublizáu en xineru de 1997 artikull shkencor i botuar më 01 janar 1997 scientific article published on 01 January 1997 наукова стаття, опублікована в січні 1997
p:P577
wds:Q73016743-515635F5-059A-44D6-B549-52F827BEB89E
wdt:P577
1997-01-01T00:00:00Z
p:P407
wds:Q73016743-CE0F45D4-DB0B-4034-B5E5-EEB2028902CC
wdt:P407
wd:Q1860
p:P2093
wds:Q73016743-9931A18A-F603-4F6D-8E2A-4FC937207D53 wds:Q73016743-B2EE28C8-E009-4CBA-BB5C-6622FF0B9840 wds:Q73016743-94C7A40F-C51D-4D6A-AB21-3FDA84DCD594 wds:Q73016743-98CEE20F-DE3B-4379-8077-24953D7F7057 wds:Q73016743-8F0F762C-C508-4E85-87F1-184C3FAFF34C wds:Q73016743-67BB264C-7CE3-4EF3-967A-C86AD957F40A wds:Q73016743-4B52D825-7EDA-46DB-92DC-329C71A59E58 wds:Q73016743-148157A7-7C12-4E52-9EC4-52D4AB06E122 wds:Q73016743-248D1626-21C4-4F5B-BD21-ECC5ED7C1EE1 wds:Q73016743-135097FA-3D72-4D9C-8E34-B0610B2491BA
wdt:P2093
Y Amasaki M Azuma S Jodo A Fujisaku Y Feng N Kayagaki N Ogura K Okumura H Yagita S Kobayashi
rdfs:label
Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases Serum levels of soluble Fas/APO-1
skos:prefLabel
Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases Serum levels of soluble Fas/APO-1 Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases
schema:name
Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases Serum levels of soluble Fas/APO-1
p:P50
wds:Q73016743-93C33E5F-F819-47AD-8128-9BA856C7BD8E
wdt:P50
wd:Q73731383
p:P1476
wds:Q73016743-B5DD52A5-6BA2-426B-A897-688A976A1304
wdt:P1476
Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases
p:P304
wds:Q73016743-0B8EC4CB-87B7-464E-8453-79086F13FF31
wdt:P304
89-95
p:P31
wds:Q73016743-78FDA8DC-854C-49C2-B265-87045888FA92
wdt:P31
wd:Q13442814
p:P921
wds:Q73016743-E62C48F8-2CEE-49AA-AEDF-D033E91D95A6
wdt:P921
wd:Q1485
p:P698
wds:Q73016743-83A41F2C-1713-430D-9B8B-31EF444D3C19
wdtn:P698
n9:9010262
wdt:P698
9010262
p:P1433
wds:Q73016743-40BBBC6D-900F-4802-BFDE-9B808B71E7B9
wdt:P1433
wd:Q15716708
p:P433
wds:Q73016743-BCFD91A9-6BEC-4D8A-8653-B0EB7ACFF7C4
p:P478
wds:Q73016743-C02DED92-15BF-4179-9AD6-6CB732C477FE
wdt:P433
1
wdt:P478
107
p:P356
wds:Q73016743-ED897DDA-B4C9-4C5A-9E77-0B81382F3A94
wdtn:P356
n10:J.1365-2249.1997.D01-901.X
wdt:P356
10.1046/J.1365-2249.1997.D01-901.X
p:P932
wds:Q73016743-F9BEB6A8-C2E1-46C6-95A8-6C63DB3050CE
wdt:P932
1904535